About
Recombinant Botulinum Toxin
Areas of Focus
Categories
BiosimilarsNJ, NY, PA
Clinical Trials (1)
View allTotal Trials
1
As Lead Sponsor
1
As Collaborator
0
Total Enrollment
1,012
By Phase
NA: 1
By Status
COMPLETED: 1
Clinical Trials Pipeline1 trial
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2011
2012
2013
2014
Today
Hover over trial bars to see details
Locations (1)
Headquarters
New York, NY, United States
Map
Loading map...